Navigation Links
Dispute in Findings about Radiation exposure

A former Army Major questioned a particular research, which revealed that there was no link between increased cancer rates among those who took part in British nuclear tests in Australia in the 1950s - and their exposure to radiation//.

According to the he Federal Government commissioned study while those who took part in the nuclear tests did have higher rates of certain cancers, it was not linked to their exposure to radiation.

However Veterans Affairs Minister, Bruce Billson, said that despite having no connection, there would be free cancer treatment for those who took part.

Former Army Major, Alan Batchelor, who was present at the nuclear test site, and participated in the study, claims the results are flawed and that there was a link.

According to him information in the study, which showed extremely high radiation levels among veterans are ignored in the findings.

He said, ‘You will find that the levels are about 200 times out. I've taken these discrepancies to both Ministers Nelson and Billson and I've spoken to the study about them but nobody seems to have taken any notice.’

While the RSL has also expressed doubts about the study they have welcomed the Government's offer of free health care for cancer sufferers involved in the atomic testing.

The Veterans Affairs Minister has yet not responded to the latest claims.


'"/>




Page: 1

Related medicine news :

1. Radiographers Pay Parity Disputes Still Unresolved
2. CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG
3. Latest Findings On The Deadly Disease - SARS
4. New Findings Could Reduce The Extent Of Spinal Cord Injuries
5. New Findings for Repeated Miscarriages
6. How Healthy Are Herbal Products? US Findings.
7. New Findings on Autism Research
8. Engineering Nutrient-Rich Plants Made For Feasible By New Findings
9. Study Findings Could Help In Developing A Better Drug Delivery System
10. Findings Suggest New Method to Fight Staph Infections
11. Most Suicide Rates Decline, but Findings Are Puzzling

Post Your Comments:
(Date:12/3/2009)...PRNewswire/ -- An exciting treatment gaining accep...latelet-rich plasma therapy (PRP), is showing stro...lant procedures, according to a prominent dental r...ntology . ,, James Rutkowski, DMD, PhD, repor... American Academy of Implant Dentistry that platel...
(Date:12/3/2009)...es rzteblatt International contains the first sci...the novel influenza A virus (H1N1/09) in the Germa...ic. Ralf Winzer and his coauthors from the Dsseldo...ata from a large clinical cohort of infected perso...770-6). Their medical-scientific article is accomp...
(Date:12/3/2009)... Deaths a day is still too many - stalled momentum... Atlanta, GA, Geneva, New York, NY a...Measles Initiative announced today that measles de...from an estimated 733 000 in 2000 to 164 000 in 20... resurgence in measles deaths if vaccination effor...
(Date:12/3/2009)...ra Pharma will be conducting a webinar on December...-counter and prescription treatments for chronic p... Plantation, FL (Vocus) December 3, 2009 -- ...company that is developing treatments for Adrenomy...S), has announced today that it will be hosting an...
(Date:12/3/2009)...f., Dec. 3 Osseon Therapeutics ann...vable bone cement delivery needle) and Osseoflex D...percutaneous vertebral augmentation received Canad... marketing and clinical use in Canada. ,, Canad... FDA approval in the United States, and allows for...
Breaking Medicine News(10 mins):Health News:Platelet-rich Plasma Enhances Bone and Tissue Growth for Dental Implants 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 3Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 4Health News:Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain 2Health News:Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain 3Health News:Osseon Therapeutics, Inc. Announces it has Received Canadian Medical Device Licenses From Health Canada 2
...rn to mothers who have low levels of foliate// in ...tudy. Folate is essential for fetal growth a... helping produce and maintain new cells. It is a B...und of folate, before conceiving and during the ea...
...ion for upgrading a medical college in Orissa.// ...allavbhai Patel Postgraduate Institute of Paediatr... and effectively contribute towards dispensation o...rsday by Japanese ambassador Yasukuni Enoki and Vi...
...th unhealthy foods could be used to treat// obesit...ersity of California, Irvine, and her colleagues c...eating strawberry ice cream as a child. She ...at suggested they had had an unpleasant experience...
...ip called Genotyper that can identify the genetic ... the doctors to treat patients effectively. D...n, the Genotyper is on its way to become fully por...fying the flu type is similar to genetic fingerpri...
...arean were less likely to conceive again //than th...new British study. Researchers led by Siladit...tain, followed women who had their first single ch...of mothers undergoing caesarean went on to have an...
...pes for a new drug to treat women with //low sexua...FDA) wants more studies to be done on the Intrinsa...ut what long-term side effects the drug may induce...ng with low desire. Though experts say femal...
Other Medicine News:Health News:Vitamin Supplements During Pregnancy to Boost Fetal Development 2Health News:Unpleasant Memory of Food could Be Used to Treat Obesity 2Health News:New Tools To Identify Flu Strains 2Health News:FDA Diminish Hopes On ‘Female Viagra 2Health News:FDA Diminish Hopes On ‘Female Viagra 3
(Date:12/3/2009)... Stryker Corporation (NY...ctors has authorized the Company to repurchase up ...timing and amount of any purchases will be determi...luation of market conditions, stock price and othe...erations. Purchases may be made from time to time...
(Date:12/3/2009)...c. 3 Decision Resources, one of ...cusing on pharmaceutical and healthcare issues, fo...azil will grow from $417 million in 2008 to $834 m...owth rate is attributed to a growing prevalent and...eration antidiabetics such as Merck,s Januvia, Nov...
(Date:12/3/2009)... 3 Honeywell (NYSE: HON ) announ... Pro-Lab Laboratuar Teknolojileri, which will dist...h-purity solvents in Turkey. ,, Burdick & J...ogy and pharmaceutical companies in the drug disco...wth rate of the Turkish pharmaceutical market is e...
Breaking Medicine Technology:Stryker Announces $750 Million Share Repurchase Program and Declares a $0.15 Per Share Quarterly Dividend 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 3Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 2Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 3Positive trend for diabetic eye health 3B AMD may predict heart disease 3B vision impacts life success 58726 1Positive trend for diabetic eye health 3B AMD may predict heart disease 3B vision impacts life success 58726 2Positive trend for diabetic eye health 3B AMD may predict heart disease 3B vision impacts life success 58726 3Duke Singapore scientists find new way to classify gastric cancers 58725 1Duke Singapore scientists find new way to classify gastric cancers 58725 2New Tools Help Emergency Planners Select Alternate Care Facilities and Transfer Patients During Disasters 58720 1New Tools Help Emergency Planners Select Alternate Care Facilities and Transfer Patients During Disasters 58720 2
...ne 3 Delcath Systems, Inc.,(Nasdaq: DCTH ) annou...thlehem, PA, part of St. Luke,s Hospital & Health ...I clinical trial for the treatment of,inoperable m...s,Percutaneous Hepatic Perfusion (PHP) System for ...r agent melphalan. This Phase III multi-center,stu...
...ed at ASCO Show 26% Partial Response, 63% Clinical... HAYWARD, Calif., June 3 Kosan Biosciences,Incorp...ead Hsp90 inhibitor,tanespimycin, demonstrated a h... when administered in combination with trastuzumab...astatic breast cancer whose disease had,either pro...
Other Medicine Technology:Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center 2Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center 3Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 2Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 3Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 4Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 5Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial 6
PVA, The Personal Vision Assistant
...elco general purpose incubators designed to provid...equired for the most demanding incubation applicat...cubators feature push-button temperature setpoint ...ilt-in over-temperature protection. Equally import...
...ecision Economy Incubators available in five diffe...on; capacities of 1.4 cu. Ft. (39 liters), 2.5 cu....ually important, Precision Economy Incubators comb...ature sensitivity, stability, and uniformity. As a...
40D Large
Medicine Products: